138 related articles for article (PubMed ID: 22388762)
21. Macroscopic, histologic, histochemical, immunohistochemical, and ultrastructural features of mesothelioma.
Hammar SP
Ultrastruct Pathol; 2006; 30(1):3-17. PubMed ID: 16517466
[TBL] [Abstract][Full Text] [Related]
22. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura.
Miettinen M; Sarlomo-Rikala M
Am J Surg Pathol; 2003 Feb; 27(2):150-8. PubMed ID: 12548160
[TBL] [Abstract][Full Text] [Related]
23. Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases.
Raju U; Fine G; Greenawald KA; Ohorodnik JM
Hum Pathol; 1989 May; 20(5):426-36. PubMed ID: 2707793
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity.
Yaziji H; Battifora H; Barry TS; Hwang HC; Bacchi CE; McIntosh MW; Kussick SJ; Gown AM
Mod Pathol; 2006 Apr; 19(4):514-23. PubMed ID: 16554731
[TBL] [Abstract][Full Text] [Related]
25. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
[TBL] [Abstract][Full Text] [Related]
26. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors.
Goldblum J; Hart WR
Am J Surg Pathol; 1995 Oct; 19(10):1124-37. PubMed ID: 7573671
[TBL] [Abstract][Full Text] [Related]
27. EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity.
Dermawan JK; Torrence D; Lee CH; Villafania L; Mullaney KA; DiNapoli S; Sukhadia P; Benayed R; Borsu L; Agaram NP; Nash GM; Dickson BC; Benhamida J; Antonescu CR
Genes Chromosomes Cancer; 2022 Oct; 61(10):592-602. PubMed ID: 35665561
[TBL] [Abstract][Full Text] [Related]
28. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas.
Ordóñez NG
Am J Surg Pathol; 1998 Oct; 22(10):1203-14. PubMed ID: 9777982
[TBL] [Abstract][Full Text] [Related]
29. HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma.
Oates J; Edwards C
Histopathology; 2000 Apr; 36(4):341-7. PubMed ID: 10759948
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases.
Sussman J; Rosai J
Am J Surg Pathol; 1990 Sep; 14(9):819-28. PubMed ID: 2389813
[TBL] [Abstract][Full Text] [Related]
31. Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.
Klebe S; Brownlee NA; Mahar A; Burchette JL; Sporn TA; Vollmer RT; Roggli VL
Mod Pathol; 2010 Mar; 23(3):470-9. PubMed ID: 20081811
[TBL] [Abstract][Full Text] [Related]
32. Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 cases.
Shia J; Qin J; Erlandson RA; King R; Illei P; Nobrega J; Yao D; Klimstra DS
Virchows Arch; 2005 Nov; 447(5):828-34. PubMed ID: 16021506
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and pathologic features of extrapleural sarcomatoid mesothelioma].
Wei MC; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):559-564. PubMed ID: 28810297
[No Abstract] [Full Text] [Related]
34. BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.
Leblay N; Leprêtre F; Le Stang N; Gautier-Stein A; Villeneuve L; Isaac S; Maillet D; Galateau-Sallé F; Villenet C; Sebda S; Goracci A; Byrnes G; McKay JD; Figeac M; Glehen O; Gilly FN; Foll M; Fernandez-Cuesta L; Brevet M
J Thorac Oncol; 2017 Apr; 12(4):724-733. PubMed ID: 28034829
[TBL] [Abstract][Full Text] [Related]
35. Malignant mesothelioma of peritoneum.
Weidner N
Ultrastruct Pathol; 1991; 15(4-5):515-20. PubMed ID: 1721749
[TBL] [Abstract][Full Text] [Related]
36. Sarcomatoid Mesothelioma: A Clinicopathological and Immunohistochemical Study of 64 Cases.
Oramas DM; Zaleski M; Moran CA
Int J Surg Pathol; 2021 Dec; 29(8):820-825. PubMed ID: 33939493
[TBL] [Abstract][Full Text] [Related]
37. [Malignant mesothelioma. Retrospective study of 16 cases].
Avril J
Schweiz Med Wochenschr; 1981 Mar; 111(10):333-42. PubMed ID: 7221510
[TBL] [Abstract][Full Text] [Related]
38. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
Klebe S; Mahar A; Henderson DW; Roggli VL
Mod Pathol; 2008 Sep; 21(9):1084-94. PubMed ID: 18587319
[TBL] [Abstract][Full Text] [Related]
39. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
40. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females.
Shanks JH; Harris M; Banerjee SS; Eyden BP; Joglekar VM; Nicol A; Hasleton PS; Nicholson AG
Am J Surg Pathol; 2000 Feb; 24(2):285-94. PubMed ID: 10680897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]